LASIK and surface ablation in patients treated with amiodarone

详细信息    查看全文

• 作者：J. Ortega-Usobiaga^a ; ^{jortega@clinicabaviera.com" class="auth_mail" title="E-mail the corresponding author} ; F. Llovet-Osuna^b ; M. Reza Djodeyre^c ; R. Cobo-Soriano^b ; A. Llovet-Rausell^d ; J. Baviera-Sabater^e
• 关键词：Amiodarone ; Laser in situ keratomileusis ; Photorefractive keratectomy ; Laser assisted sub-epithelial keratectomy ; Surface ablation
• 刊名：Archivos de la Sociedad Española de Oftalmología (English Edition)
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：91
• 期：11
• 页码：520-525
• 全文大小：990 K

文摘

To determine the anatomical and functional outcomes of corneal refractive surgery in patients on amiodarone, a drug listed as being contraindicated in patients undergoing this procedure.

absSec_2">Material and methods

ar0010">A retrospective observational study was conducted on all consecutive patients who took amiodarone and who underwent LASIK or surface ablation from January 2003 to December 2014. Functional (visual and refractive) outcomes are described.

absSec_3">Results

ar0015">A total of 20 patients (33 eyes) were included. No significant intraoperative or postoperative complications were found.

absSec_4">Conclusions

ar0020">In our experience, LASIK and surface ablation did not produce significant clinical complications in selected patients taking amiodarone. The absolute exclusion of certain systemic medications should be reconsidered.